Article
Autologous tumor cell killing activity of tumor-associated lymphocytes in patients with head and neck carcinomas.
Biotherapy (Dordrecht, Netherlands) - 1 Jan 1993
Tsukuda M, Mochimatsu I, Sakumoto M, Furukawa S, Yuyama S, Yanoma S, Kubota A
Abstract excerpt
In order to select the most cytotoxic effector cells for adoptive immunotherapy, lymphokine activated killer (LAK) cells, tumor infiltrating lymphocytes (TILs) and autologous mixed lymphocyte tumor cell culture (MLTC) cells derived from peripheral blood mononuclear cells (PBMC) in the same subject with head and neck carcinomas were prepared. The autologous tumor cell killing activity and cell surface phenotypes...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
